Register Cart 0

Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back Subscribe

Editorial [Hot Topic:Applications of Angiotensin Converting Enzyme Inhibitors and of Angiotensin II Receptor Blockers in Pharmacology and Therapy: An Update (Executive Editor: Agostino Molteni)]

Author(s): Agostino Molteni

Volume 13, Issue 12, 2007

Page: [1187 - 1190] Pages: 4

DOI: 10.2174/138161207780618894

Next »

Rights & Permissions Print Cite

Article Metrics

8

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

Drugs Targeting Parasite Lysosomes
Current Pharmaceutical Design

Potential Therapeutic Advantages of Doxorubicin when Activated by Formaldehyde to Function as a DNA Adduct-Forming Agent
Current Topics in Medicinal Chemistry

HER2 in the Era of Molecular Medicine: A Review
Current Cancer Therapy Reviews

LCHAD and MTP Deficiencies - Two Disorders of Mitochondrial Fatty Acid β-Oxidation with Unusual Features
Current Pediatric Reviews

Breath Tests to Assess Alcoholic Liver Disease
Reviews on Recent Clinical Trials

Diabetes and Antioxidants: Myth or Reality?
Current Vascular Pharmacology

Tako-tsubo Cardiomyopathy: A Review of the Literature
Current Cardiology Reviews

Recent Advances in Exercise Testing
Current Cardiology Reviews

Diagnostic Value of HLA Typing in Pathogenesis of Cardiomyopathy
Cardiovascular & Hematological Disorders-Drug Targets

Meet the Editorial Board
Current Drug Targets

Acute Coronary Syndromes in Patients with Atrial Fibrillation and Heart Failure. Could Novel Oral Anticoagulants be the Solution of the Optimal Antithrombotic Therapy Puzzle?
Cardiovascular & Hematological Agents in Medicinal Chemistry

Transition of Care for Patients with Diabetes
Current Diabetes Reviews

Cardioprotection by Targeting the Pool of Resident and Extracardiac Progenitors
Current Drug Targets

Lipoprotein Subfractions, Uric Acid and Cardiovascular Risk in End-Stage Renal Disease (ESRD) Patients
Current Vascular Pharmacology

Common Pathways in Health Benefit Properties of RSV in Cardiovascular Diseases, Cancers and Degenerative Pathologies
Current Pharmaceutical Biotechnology

Patent Selections:
Recent Patents on CNS Drug Discovery (Discontinued)

Use of Clinically Available PPAR Agonists for Heart Failure; Do the Risks Outweigh the Potential Benefits?
Current Molecular Pharmacology

Bariatric Surgery and it Effects on the Respiratory System
Current Respiratory Medicine Reviews

Chromogranin-A: A Multifaceted Cardiovascular Role in Health and Disease
Current Medicinal Chemistry

Cardiac Aging and Insulin Resistance: Could Insulin/Insulin-Like Growth Factor (IGF) Signaling be used as a Therapeutic Target?
Current Pharmaceutical Design

© 2025 Bentham Science Publishers | Privacy Policy